Catherine A. Brandon

"Can You Hear Me Now?": DOJ Expands Telehealth Enforcement Efforts

CFPB, HHS, And Treasury Launch Inquiry Into Medical Payment Products

Subpoenas At The Ready: The 118th Congress Is Poised To Investigate

Biden Administration Issues Rules Requiring Insurer Transparency On Drug Spending, Rebates And Fees: What Manufacturers Need To Know

A New Federal Umpire: What Healthcare Providers Need To Know About Surprise Medical Billing Under The No Surprises Act

HHS Finalizes New Protections For Value-Based Arrangements And Other Revisions To The Anti-Kickback Statute Safe Harbors And Civil Monetary Penalties Exceptions

Pharmacy Point-Of-Sale Price Concession And PBM Service Fee Safe Harbor Final Rule May Reshape Medicare Part D: What Pharmaceutical Manufacturers Need To Know Now

Post-Election Analysis 2020: Life Sciences & Healthcare

Navigating The Post-Election Landscape: Life Sciences & Healthcare

Navigating COVID-19 Related Congressional Investigations (Video)

Medicare And FCC Take Additional Steps To Support The Frontline Battling COVID-19

HHS Proposes New Protections For Value-Based Arrangements And Other Revisions To AKS Safe Harbors, CMP Exceptions And Stark Exceptions

HHS OIG's Proposed Rule: Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals

Is DOJ Feeling Charitable? DOJ Files Statement Of Interest Regarding Manufacturer Donations To Charity Patient Assistance Programs